Drug discovery

Galecto raises €79 million in Series C round

Read more

RNA therapeutics are now a clinical reality

Read more

Genmab looks ahead to next phase of growth

Read more

The oncology drug success rate is improving

Read more

After probing the unknown, BerGenBio finds a gem

Read more

Altheia Science Srl: Italian biotech raises $11 mln for autoimmunity

Read more

Targeting the genetic background of cancers

Read more

A new technology for targeting proteins inside cells

Read more

Unlocking the potential of single cell analysis

Read more

Organs-on-chips enter the laboratories of big pharma

Read more